Vancouver-based Zenabis recalls CBD gelcaps in New Brunswick, which contain THC due to incorrect labelling

    1 of 1 2 of 1

      A cannabis company, which has its headquarters in Vancouver, is recalling one of its products due to improper labelling.

      Health Canada announced on December 17 that Zenabis is recalling its Namaste CBD Light Softgels gelcaps sold in New Brunswick.

      Although the label states that the units contain CBD Light gelcaps, the containers incorrectly have THC gelcaps inside them instead.

      The affected product, sold through the provincially run Cannabis NB in New Brunswick, is sold in 0.22 millilitre units with 15 capsules per unit, and has lot number 1000321.

      The printed values on the label are:

      THC: 0.19 mg/capsule
      CBD: 6.13 mg/capsule
      Total potential THC: 0.19mg/capsule
      Total potential CBD: 6.13mg/capsule

      However, the actual values are:

      THC: 2.247mg/capsule
      CBD: 0.00 mg/capsule
      Total potential THC: 2.28 mg/capsule
      Total potential CBD: 0.00 mg/capsule

      A total of 165 units were sold on October 7.

      Zenabis has received one complaint thus far in relation to this error while Health Canada hasn’t received any complaints yet.

      No adverse reactions have been reported yet.  

      Any health or safety complaints related to this cannabis product (or any other cannabis product) can fill out an online complaint form.

      Health Canada advises anyone who has this product to return it to the place of purchase. For additional information, customers can contact Cannabis NB at 1-833-821-2195.

      The recalling firm is listed as Zenabis in New Brunswick, where it operates a growing facility in Atholville.

      However, Zenabis has its head office in Vancouver, a greenhouse in Langley, and a research and development facility in Delta.

      Comments